BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32613609)

  • 41. SHIP inhibition mediates select TREM2-induced microglial functions.
    Ramakrishnan GS; Berry WL; Pacherille A; Kerr WG; Chisholm JD; Pedicone C; Humphrey MB
    Mol Immunol; 2024 Jun; 170():35-45. PubMed ID: 38613944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Established Beta Amyloid Pathology Is Unaffected by TREM2 Elevation in Reactive Microglia in an Alzheimer's Disease Mouse Model.
    Yuan Q; Liu X; Zhang Y; Xian YF; Zou J; Zhang X; Huang P; Song YQ; Lin ZX
    Molecules; 2021 May; 26(9):. PubMed ID: 34064330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
    Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z
    J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a
    Parhizkar S; Gent G; Chen Y; Rensing N; Gratuze M; Strout G; Sviben S; Tycksen E; Zhang Q; Gilmore PE; Sprung R; Malone J; Chen W; Remolina Serrano J; Bao X; Lee C; Wang C; Landsness E; Fitzpatrick J; Wong M; Townsend R; Colonna M; Schmidt RE; Holtzman DM
    Sci Transl Med; 2023 Apr; 15(693):eade6285. PubMed ID: 37099634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.
    Zhou Y; Song WM; Andhey PS; Swain A; Levy T; Miller KR; Poliani PL; Cominelli M; Grover S; Gilfillan S; Cella M; Ulland TK; Zaitsev K; Miyashita A; Ikeuchi T; Sainouchi M; Kakita A; Bennett DA; Schneider JA; Nichols MR; Beausoleil SA; Ulrich JD; Holtzman DM; Artyomov MN; Colonna M
    Nat Med; 2020 Jan; 26(1):131-142. PubMed ID: 31932797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
    Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
    Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Up-regulation of TREM2 accelerates the reduction of amyloid deposits and promotes neuronal regeneration in the hippocampus of amyloid beta1-42 injected mice.
    Fan Y; Ma Y; Huang W; Cheng X; Gao N; Li G; Tian S
    J Chem Neuroanat; 2019 Apr; 97():71-79. PubMed ID: 30790627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
    Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
    FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
    McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
    Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
    Wang S; Sudan R; Peng V; Zhou Y; Du S; Yuede CM; Lei T; Hou J; Cai Z; Cella M; Nguyen K; Poliani PL; Beatty WL; Chen Y; Cao S; Lin K; Rodrigues C; Ellebedy AH; Gilfillan S; Brown GD; Holtzman DM; Brioschi S; Colonna M
    Cell; 2022 Oct; 185(22):4153-4169.e19. PubMed ID: 36306735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia.
    Zhao N; Qiao W; Li F; Ren Y; Zheng J; Martens YA; Wang X; Li L; Liu CC; Chen K; Zhu Y; Ikezu TC; Li Z; Meneses AD; Jin Y; Knight JA; Chen Y; Bastea L; Linares C; Sonustun B; Job L; Smith ML; Xie M; Liu YU; Umpierre AD; Haruwaka K; Quicksall ZS; Storz P; Asmann YW; Wu LJ; Bu G
    J Exp Med; 2022 Dec; 219(12):. PubMed ID: 36107206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
    Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
    Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.
    Das M; Mao W; Voskobiynyk Y; Necula D; Lew I; Petersen C; Zahn A; Yu GQ; Yu X; Smith N; Sayed FA; Gan L; Paz JT; Mucke L
    Neurobiol Dis; 2023 Oct; 186():106263. PubMed ID: 37591465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.
    Sayed FA; Telpoukhovskaia M; Kodama L; Li Y; Zhou Y; Le D; Hauduc A; Ludwig C; Gao F; Clelland C; Zhan L; Cooper YA; Davalos D; Akassoglou K; Coppola G; Gan L
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10172-10177. PubMed ID: 30232263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
    Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
    MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
    Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
    FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
    Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
    Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
    EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.